Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Counselors’ Experience with Cell‐Free Fetal DNA Testing as a Prenatal Screening Option for Aneuploidy

18 Dec 2013

Abstract excerpt

First identified in 1997, cell-free fetal DNA (cffDNA) has just recently been used to detect fetal aneuploidy of chromosomes 13, 18, and 21, showing its potential to revolutionize prenatal genetic testing as a non-invasive screening tool. Although this technological advancement is exciting and has certain medical applications, it has been unclear how it will be implemented in a clinical setting. Genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24352524
DOI: 10.1007/s10897-013-9673-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Counselors’ Experience with Cell‐Free Fetal DNA Testing as a Prenatal Screening Option for AneuploidyPMID 24352524Read ↗

Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US contextSemantic proximity Read ↗

Cell‐free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementationSemantic proximity Read ↗

Recommended pre‐test counseling points for noninvasive prenatal testing using cell‐free DNA: a 2015 perspectiveSemantic proximity Read ↗

Patient attitudes and preferences about expanded noninvasive prenatal testingSemantic proximity Read ↗

The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy populationSemantic proximity Read ↗

Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issuesSemantic proximity Read ↗

NIPT: current utilization and implications for the future of prenatal genetic counselingSemantic proximity Read ↗

Prenatal Genetic Diagnosis of a Sex Chromosome Aneuploidy: Parent ExperiencesSemantic proximity Read ↗

Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA)Semantic proximity Read ↗

Cell-free DNA for the detection of fetal aneuploidy.Semantic proximity Read ↗

An Exploration of Genetic Counselors’ Needs and Experiences with Prenatal Chromosomal Microarray TestingSemantic proximity Read ↗

“If it helps …” the use of microarray technology in prenatal testing: Patient and partners reflectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.